Literature DB >> 24442332

A framework for crafting clinical practice guidelines that are relevant to the care and management of people with multimorbidity.

Katrin Uhlig1, Bruce Leff, David Kent, Sydney Dy, Klara Brunnhuber, Jako S Burgers, Sheldon Greenfield, Gordon Guyatt, Kevin High, Rosanne Leipzig, Cynthia Mulrow, Kenneth Schmader, Holger Schunemann, Louise C Walter, James Woodcock, Cynthia M Boyd.   

Abstract

Many patients of all ages have multiple conditions, yet clinicians often lack explicit guidance on how to approach clinical decision-making for such people. Most recommendations from clinical practice guidelines (CPGs) focus on the management of single diseases, and may be harmful or impractical for patients with multimorbidity. A major barrier to the development of guidance for people with multimorbidity stems from the fact that the evidence underlying CPGs derives from studies predominantly focused on the management of a single disease. In this paper, the investigators from the Improving Guidelines for Multimorbid Patients Study Group present consensus-based recommendations for guideline developers to make guidelines more useful for the care of people with multimorbidity. In an iterative process informed by review of key literature and experience, we drafted a list of issues and possible approaches for addressing important coexisting conditions in each step of the guideline development process, with a focus on considering relevant interactions between the conditions, their treatments and their outcomes. The recommended approaches address consideration of coexisting conditions at all major steps in CPG development, from nominating and scoping the topic, commissioning the work group, refining key questions, ranking importance of outcomes, conducting systematic reviews, assessing quality of evidence and applicability, summarizing benefits and harms, to formulating recommendations and grading their strength. The list of issues and recommendations was reviewed and refined iteratively by stakeholders. This framework acknowledges the challenges faced by CPG developers who must make complex judgments in the absence of high-quality or direct evidence. These recommendations require validation through implementation, evaluation and refinement.

Entities:  

Mesh:

Year:  2014        PMID: 24442332      PMCID: PMC3965742          DOI: 10.1007/s11606-013-2659-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  53 in total

Review 1.  Credibility of claims of subgroup effects in randomised controlled trials: systematic review.

Authors:  Xin Sun; Matthias Briel; Jason W Busse; John J You; Elie A Akl; Filip Mejza; Malgorzata M Bala; Dirk Bassler; Dominik Mertz; Natalia Diaz-Granados; Per Olav Vandvik; German Malaga; Sadeesh K Srinathan; Philipp Dahm; Bradley C Johnston; Pablo Alonso-Coello; Basil Hassouneh; Stephen D Walter; Diane Heels-Ansdell; Neera Bhatnagar; Douglas G Altman; Gordon H Guyatt
Journal:  BMJ       Date:  2012-03-15

2.  Reconsidering the approach to prevention recommendations for older adults.

Authors:  Rosanne M Leipzig; Evelyn P Whitlock; Tracy A Wolff; Mary B Barton; Yvonne L Michael; Russell Harris; Diana Petitti; Timothy Wilt; Al Siu
Journal:  Ann Intern Med       Date:  2010-12-21       Impact factor: 25.391

Review 3.  Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Samantha MacLean; Sohail Mulla; Elie A Akl; Milosz Jankowski; Per Olav Vandvik; Shanil Ebrahim; Shelley McLeod; Neera Bhatnagar; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

5.  Comparing the USPSTF and GRADE approaches to recommendations.

Authors:  Gordon H Guyatt; Mark Helfand; Regina Kunz
Journal:  Ann Intern Med       Date:  2009-09-01       Impact factor: 25.391

6.  Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.

Authors:  David M Kent; Rodney A Hayward
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

Review 7.  Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials.

Authors:  Donna M Zulman; Jeremy B Sussman; Xisui Chen; Christine T Cigolle; Caroline S Blaum; Rodney A Hayward
Journal:  J Gen Intern Med       Date:  2011-02-01       Impact factor: 5.128

8.  Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.

Authors:  Cynthia M Boyd; Jonathan Darer; Chad Boult; Linda P Fried; Lisa Boult; Albert W Wu
Journal:  JAMA       Date:  2005-08-10       Impact factor: 56.272

9.  Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers.

Authors:  Amy C Justice; K A McGinnis; M Skanderson; C C Chang; C L Gibert; M B Goetz; D Rimland; M C Rodriguez-Barradas; K K Oursler; S T Brown; R S Braithwaite; M May; K E Covinsky; M S Roberts; S L Fultz; K J Bryant
Journal:  HIV Med       Date:  2009-09-14       Impact factor: 3.180

10.  High prevalence of potential biases threatens the interpretation of trials in patients with chronic disease.

Authors:  Daniela Vollenweider; Cynthia M Boyd; Milo A Puhan
Journal:  BMC Med       Date:  2011-06-13       Impact factor: 8.775

View more
  63 in total

Review 1.  Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.

Authors:  Robert A Adler; Ghada El-Hajj Fuleihan; Douglas C Bauer; Pauline M Camacho; Bart L Clarke; Gregory A Clines; Juliet E Compston; Matthew T Drake; Beatrice J Edwards; Murray J Favus; Susan L Greenspan; Ross McKinney; Robert J Pignolo; Deborah E Sellmeyer
Journal:  J Bone Miner Res       Date:  2016-01       Impact factor: 6.741

2.  Eliciting Values of Patients with Multiple Chronic Conditions: Evaluation of a Patient-centered Framework.

Authors:  Andrew B L Berry; Catherine Lim; Andrea L Hartzler; Tad Hirsch; Evette Ludman; Edward H Wagner; James D Ralston
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

3.  Evidence-based medicine and the hard problem of multimorbidity.

Authors:  Cynthia M Boyd; David M Kent
Journal:  J Gen Intern Med       Date:  2014-01-18       Impact factor: 5.128

Review 4.  Addressing multimorbidity in evidence integration and synthesis.

Authors:  Thomas A Trikalinos; Jodi B Segal; Cynthia M Boyd
Journal:  J Gen Intern Med       Date:  2014-01-18       Impact factor: 5.128

5.  Engaging Stakeholders to Inform Clinical Practice Guidelines That Address Multiple Chronic Conditions.

Authors:  Wendy L Bennett; Craig W Robbins; Elizabeth A Bayliss; Renee Wilson; Heather Tabano; Richard A Mularski; Wiley V Chan; Milo Puhan; Tsung Yu; Bruce Leff; Tianjing Li; Kay Dickersin; Carol Glover; Katie Maslow; Karen Armacost; Suzanne Mintz; Cynthia M Boyd
Journal:  J Gen Intern Med       Date:  2017-03-27       Impact factor: 5.128

6.  The Ethics of Deprescribing in Older Adults.

Authors:  Emily Reeve; Petra Denig; Sarah N Hilmer; Ruud Ter Meulen
Journal:  J Bioeth Inq       Date:  2016-07-14       Impact factor: 1.352

7.  Multimorbidity in Older Patients with Cardiovascular Disease.

Authors:  Shannon M Dunlay; Alanna M Chamberlain
Journal:  Curr Cardiovasc Risk Rep       Date:  2016-01-26

Review 8.  Multimorbidity and cardiovascular disease: a perspective on low- and middle-income countries.

Authors:  Friedrich Thienemann; Ntobeko A B Ntusi; Edouard Battegay; Beatrice U Mueller; Marcus Cheetham
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

9.  Understanding What Is Most Important to Individuals with Multiple Chronic Conditions: A Qualitative Study of Patients' Perspectives.

Authors:  Catherine Y Lim; Andrew B L Berry; Tad Hirsch; Andrea L Hartzler; Edward H Wagner; Evette J Ludman; James D Ralston
Journal:  J Gen Intern Med       Date:  2017-08-28       Impact factor: 5.128

Review 10.  Multimorbidity and evidence generation.

Authors:  Carlos O Weiss; Ravi Varadhan; Milo A Puhan; Andrew Vickers; Karen Bandeen-Roche; Cynthia M Boyd; David M Kent
Journal:  J Gen Intern Med       Date:  2014-01-18       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.